Literature DB >> 7688948

A type-specific conformational epitope on the nucleocapsid of equid herpesvirus-1 and its use in diagnosis.

A van de Moer1, M Rice, C R Wilks.   

Abstract

A type-specific monoclonal antibody was produced by immunizing mice with purified equid herpesvirus-1 (EHV-1). The EHV-1 specific mAb reacted with all the EHV-1 strains tested so far by indirect ELISA, immunofluorescence, and immunoperoxidase tests. No reactions were detected with the EHV-4, EHV-2, or EHV-3 strains tested. The indirect immunofluorescence and immunoperoxidase tests showed that the nuclei of infected cells were predominantly stained by this mAb. Triton treatment of the virus and immunogold labeling experiments indicated that the nucleocapsid of EHV-1 was the target antigen of the mAb. Preliminary results indicated that this mAb might be a useful tool in detecting specific antibody in horses that have been exposed to EHV-1. In a blocking ELISA, antibodies in sera from hamsters, mice and a foal which had been exposed to EHV-1 were differentiated from those in sera of animals exposed to EHV-4.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688948     DOI: 10.1007/bf01309848

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Amplification and differentiation of the DNA of an abortigenic (type 1) and a respiratory (type 4) strain of equine herpesvirus by the polymerase chain reaction.

Authors:  J S O'Keefe; A Murray; C R Wilks; K M Moriarty
Journal:  Res Vet Sci       Date:  1991-05       Impact factor: 2.534

2.  Proteins specified by herpes simplex virus. 8. Characterization and composition of multiple capsid forms of subtypes 1 and 2.

Authors:  W Gibson; B Roizman
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

3.  Purification of african malignant catarrhal fever virus using a two-phase aqueous polymer system.

Authors:  G M Schloer; S S Breese
Journal:  J Gen Virol       Date:  1982-03       Impact factor: 3.891

4.  Differentiation of sub-types of equine herpesvirus I by restriction endonuclease analysis.

Authors:  M Sabine; G R Robertson; J M Whalley
Journal:  Aust Vet J       Date:  1981-03       Impact factor: 1.281

5.  Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model.

Authors:  A Stokes; A H Corteyn; L A Pullen; T R Doel; D M Meredith; R A Killington; I W Halliburton; G R Whittaker; L A Wheldon; L Nicolson
Journal:  J Gen Virol       Date:  1991-04       Impact factor: 3.891

6.  Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Authors:  P X Guo; S Goebel; S Davis; M E Perkus; B Languet; P Desmettre; G Allen; E Paoletti
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs.

Authors:  M Kit; S Kit
Journal:  Vet Microbiol       Date:  1991-07       Impact factor: 3.293

8.  Protein kinase activity in equine herpesvirus.

Authors:  C C Randall; H W Rogers; D N Downer; G A Gentry
Journal:  J Virol       Date:  1972-02       Impact factor: 5.103

9.  Characterization of enveloped tegument structures (L particles) produced by alphaherpesviruses: integrity of the tegument does not depend on the presence of capsid or envelope.

Authors:  J McLauchlan; F J Rixon
Journal:  J Gen Virol       Date:  1992-02       Impact factor: 3.891

10.  Rapid diagnosis and characterization of equid herpesvirus 1 using monoclonal antibodies.

Authors:  N Edington; C G Bridges; S C Broad
Journal:  Tierarztl Prax Suppl       Date:  1987
View more
  1 in total

1.  Development of a neutralizing monoclonal antibody-based blocking ELISA for detection of equine herpesvirus 1 antibodies.

Authors:  B K Singh; S Ahuja; B R Gulati
Journal:  Vet Res Commun       Date:  2004-07       Impact factor: 2.459

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.